D. Baykiz Et Al. , "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.," Clinical laboratory , vol.68, no.12, 2022
Baykiz, D. Et Al. 2022. Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.. Clinical laboratory , vol.68, no.12 .
Baykiz, D., Emet, S., Ayduk-Govdeli, E., Kaytaz, M., Yavuz, M. L., Karaca-Ozer, P., ... Karaayvaz, E. B.(2022). Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.. Clinical laboratory , vol.68, no.12.
Baykiz, Derya Et Al. "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.," Clinical laboratory , vol.68, no.12, 2022
Baykiz, Derya Et Al. "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.." Clinical laboratory , vol.68, no.12, 2022
Baykiz, D. Et Al. (2022) . "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.." Clinical laboratory , vol.68, no.12.
@article{article, author={Derya Baykiz Et Al. }, title={Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.}, journal={Clinical laboratory}, year=2022}